Skip to main content
Atrás
Watch Compare

FRACTYL HEALTH, INC.

Calidad de datos: 83%
GUTS
NASDAQ Manufacturing Measuring & Analyzing Instruments
$0.46
▼ $0.01 (-2.09%)
Cap. Mercado: 72.50 M
Precio
$0.46
Cap. Mercado
72.50 M
Rango del Día
—
Rango de 52 Semanas
—
Volumen
—
Apertura —
Promedio 50D / 200D
—
Promedio 50D / 200D
—

Quick Summary

Puntos Clave

Negative free cash flow of -90.89 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
N/A
ROIC-112.67%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio4.27
Interest CoverageN/A

Valoración

PE (TTM)
-0.51
Above sector avg (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1366 pares)
Métrica Acción Mediana del Sector
P/E -0.5 -1.5
P/B — 1.6
ROE % — -53.6
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Precio Objetivo de Analistas

5 analistas
Buy
Actual
$0.46
+1039.1%
Objetivo
$5.24
$2.00
$6.20
$8.00
Pronóstico
P/E Futuro -0.81
EPS Futuro -$0.57
Ingresos Est. 29.77 M

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2027 -$0.57
-$0.81 – -$0.38
 29.77 M 5
FY2026 -$0.65
-$0.80 – -$0.58
 0.0 5

Sorpresas de Ganancias

Últimos 4 trimestres
Trimestre EPS Est. EPS Real Sorpresa
Q42025 -$0.18 -$0.07 +61.1%
Q32025 -$0.32 -$0.71 -124.7%
Q22025 -$0.36 -$0.57 -58.3%
Q12025 -$0.50 -$0.49 +2.0%

ETFs Holding This Stock

BRSIX BRSIX
0.08% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -140.95 M
ROE N/A ROA -159.92%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -90.89 M
ROIC -112.67% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4.27
Interest Coverage N/A Asset Turnover N/A
Working Capital 61.02 M Tangible Book Value -3.18 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.51 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -125.35%
Market Cap 72.50 M Enterprise Value -5.15 M
Per Share
EPS (Diluted TTM) -1.86 Revenue / Share N/A
FCF / Share -0.57 OCF / Share -0.57
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 64.48%
SBC-Adj. FCF -100.93 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024
Revenue — —
Net Income -140.95 M -68.69 M
EPS (Diluted) -1.86 -1.62
Gross Profit 43,000.0 43,000.0
Operating Income -96.82 M -93.53 M
EBITDA — —
R&D Expenses 74.54 M 70.47 M
SG&A Expenses 22.28 M 23.10 M
D&A — —
Interest Expense — —
Income Tax 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024
Total Assets 121.40 M 108.08 M
Total Liabilities 111.94 M 79.65 M
Shareholders' Equity 9.46 M 28.42 M
Total Debt — —
Cash & Equivalents 81.54 M 67.46 M
Current Assets 87.58 M 71.76 M
Current Liabilities 18.33 M 19.78 M